Detalhe da pesquisa
1.
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial.
Clin Infect Dis
; 76(3): e216-e226, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762834
2.
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.
Clin Infect Dis
; 74(9): 1623-1630, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309648
3.
A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis.
Clin Infect Dis
; 73(2): e304-e311, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556176
4.
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Lancet
; 395(10238): 1695-1704, 2020 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32401715
5.
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.
Gastroenterology
; 159(1): 81-95, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251668
6.
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury.
Circ J
; 84(11): 2027-2031, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981925
7.
Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice.
Arch Virol
; 163(9): 2349-2358, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736671
8.
Unexpectedly Higher Morbidity and Mortality of Hospitalized Elderly Patients Associated with Rhinovirus Compared with Influenza Virus Respiratory Tract Infection.
Int J Mol Sci
; 18(2)2017 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28134768
9.
Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant.
Front Cell Infect Microbiol
; 13: 1213806, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645378
10.
Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test.
Microbiol Spectr
; 10(2): e0099321, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254121
11.
A Computational Approach to Identification of Candidate Biomarkers in High-Dimensional Molecular Data.
Diagnostics (Basel)
; 12(8)2022 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010347
12.
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.
EBioMedicine
; 79: 103986, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398786
13.
Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples.
Diagnostics (Basel)
; 11(10)2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34679455
14.
Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant.
Diagnostics (Basel)
; 11(12)2021 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34943453
15.
In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19.
Diagnostics (Basel)
; 11(12)2021 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34943583
16.
The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum.
EBioMedicine
; 71: 103544, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34419925
17.
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
Lancet Infect Dis
; 20(9): 1051-1060, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32539986
18.
Serum neutralisation of the SARS-CoV-2 omicron sublineage BA.2.
Lancet Microbe
; 3(6): e404, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373159
19.
Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes.
Cardiol J
; 29(4): 702-706, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35578759
20.
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Chest
; 151(5): 1069-1080, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27884765